Compare · CHE vs TOI
CHE vs TOI
Side-by-side comparison of Chemed Corp (CHE) and The Oncology Institute Inc. (TOI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and TOI operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $6.74B, about 13.1x TOI ($512.9M).
- CHE has hit the wire 6 times in the past 4 weeks while TOI has been quiet.
- TOI has more recent analyst coverage (8 ratings vs 7 for CHE).
- Company
- Chemed Corp
- The Oncology Institute Inc.
- Price
- $511.70-0.54%
- $5.12+5.13%
- Market cap
- $6.74B
- $512.9M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 6
- 0
- Recent ratings
- 7
- 8
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
The Oncology Institute Inc.
The Oncology Institute, Inc. provides cancer awareness, prevention, diagnosis, treatment, and education service. The company offers chemotherapy education, comprehensive lab testing, pain management, financial counseling, end of life counseling, dietary counseling, in-house infusion center, in-house support groups, in-house pharmacy, nutraceuticals, clinical trials, and educational seminars. It also operates the hope, health, and healing center to offer patients alternative and holistic treatments in addition to chemotherapy. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Latest CHE
- Executive vice president Lee Spencer S exercised 12,099 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 11,160 units of Capital Stock, increasing direct ownership by 7% to 14,851 units (SEC Form 4)
- Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
- President and CEO Mcnamara Kevin J sold $1,026,900 worth of Capital Stock (2,000 units at $513.45), decreasing direct ownership by 3% to 66,418 units (SEC Form 4)
- Vice president Hutton Thomas C exercised 4,629 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 4,270 units of Capital Stock, increasing direct ownership by 1% to 32,840 units (SEC Form 4)
- UBS initiated coverage on Chemed with a new price target
- President and CEO Mcnamara Kevin J sold $1,002,800 worth of Capital Stock (2,000 units at $501.40), decreasing direct ownership by 3% to 68,418 units (SEC Form 4)
- Roto-Rooter Buys Largest Franchisee Territory
- Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)
Latest TOI
- The Oncology Institute Inc. filed SEC Form 8-K: Leadership Update
- Director Hively Brad sold $1,946,310 worth of shares (298,853 units at $6.51), decreasing direct ownership by 42% to 411,976 units (SEC Form 4)
- The Oncology Institute Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Large owner Chernett Jorey bought $78,480 worth of shares (12,000 units at $6.54), increasing direct ownership by 0.11% to 10,660,858 units (SEC Form 4)
- SEC Form 10-Q filed by The Oncology Institute Inc.
- The Oncology Institute Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Oncology Institute Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- The Oncology Institute Rebrands as Starling Oncology
- Director Kaushal Mohit was granted 33,133 shares, increasing direct ownership by 19% to 205,716 units (SEC Form 4)
- Director Mcgeorge Anne was granted 41,165 shares, increasing direct ownership by 14% to 332,535 units (SEC Form 4)